FDA approves Spravato nasal spray as a standalone treatment for depression in adults
The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.
NJBIZ8d
J&J’s ketamine-based drug approved as standalone treatment
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Funding Indiana's Medicaid forecast
Funding Indiana's Medicaid forecast ...
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
BioSpace16d
icotec Announces FDA clearance for Spinal Infection Indication with BlackArmor® Implants
Furthermore, following the FDA decision, Centers for Medicare and Medicaid Services (CMS) approved BlackArmor® for New Technology Add-on Payment (NTAP), which is awarded when innovative medical ...
Education Week28d
Biden Administration Scraps Medicaid Change for Special Ed. Services
The U.S. Department of Education is withdrawing a proposal that sought to streamline how schools bill Medicaid for the mental health and medical services they provide to students, partially with ...